Article Details
Retrieved on: 2021-09-24 12:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca and Daiichi Sankyo's Enhertu delivered a massive advantage over Roche's rival antibody-drug conjugate Kadcyla at slowing tumor progression in ...
Article found on: www.fiercepharma.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here